Alcon, Inc., an eye care company, researches, develops, manufactures, distributes and sells eye care products for eye care professionals and their patients around the world. The company is headquartered in Geneva, Switzerland.
| Revenue (TTM) | $10.63B |
| Gross Profit (TTM) | $5.97B |
| EBITDA | $2.31B |
| Operating Margin | 12.20% |
| Return on Equity | 3.71% |
| Return on Assets | 2.55% |
| Revenue/Share (TTM) | $21.65 |
| Book Value | $45.38 |
| Price-to-Book | 1.51 |
| Price-to-Sales (TTM) | 3.24 |
| EV/Revenue | 3.475 |
| EV/EBITDA | 14.55 |
| Quarterly Earnings Growth (YoY) | -44.60% |
| Quarterly Revenue Growth (YoY) | 9.40% |
| Shares Outstanding | $487.70M |
| Float | $486.15M |
| % Insiders | 0.17% |
| % Institutions | 66.38% |
Volatility is currently expanding
GenAI creates new opportunities for ISRG, ALC and LIVN, even as regulatory, inflation and industry headwinds continue to pressure MedTech.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
ISRG, IDXX and ALC are three AI-driven medical device laggards with strong business momentum and improving earnings estimates for a potential 2H rebound.
ALC is developing adjustable presbyopia-correcting lenses that pair advanced optics with post-surgery light adjustment.
DELL, Brinker International, Tapestry and Alcon pair strong interest coverage with solid growth prospects amid elevated borrowing costs.
The mean of analysts' price targets for Alcon (ALC) points to a 27.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Investors looking for stocks in the Medical - Instruments sector might want to consider either Alcon (ALC) or Idexx Laboratories (IDXX). But which of these two companies is the best option for those looking for undervalued stocks?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Alcon's new platforms, lenses and dry eye momentum support growth, but macro pressures, tariffs and fierce competition weigh on its outlook.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on ALC and any ticker you trade — then tracks every position and per-strategy win rate.
